0001214659-21-002783.txt : 20210305
0001214659-21-002783.hdr.sgml : 20210305
20210305163036
ACCESSION NUMBER: 0001214659-21-002783
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190723
FILED AS OF DATE: 20210305
DATE AS OF CHANGE: 20210305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHESS ROBERT
CENTRAL INDEX KEY: 0001227886
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 21718865
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4/A
1
marketforms-51612.xml
PRIMARY DOCUMENT
X0306
4/A
2019-07-23
2019-10-09
0001581280
Twist Bioscience Corp
TWST
0001227886
CHESS ROBERT
C/O TWIST BIOSCIENCE CORPORATION
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO
CA
94158
true
false
false
false
Director Stock Option (right to buy)
30.41
2019-07-23
4
A
false
10588
0.00
A
2029-07-22
Common Stock
10588
10588
D
The Form 4 originally filed on October 9,2019 incorrectly reported 5,590 options.
100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date.
/s/ William Solis, as Attorney-in-Fact for Robert Chess
2021-03-05